BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8135489)

  • 1. Intraperitoneal administration of cisplatin and etoposide during surgery for patients with gastric cancer.
    Tsujitani S; Watanabe A; Abe Y; Maehara Y; Sugimachi K; Kaibara N
    Anticancer Res; 1993; 13(6B):2497-9. PubMed ID: 8135489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal cisplatin during surgery for gastric cancer and peritoneal seeding.
    Tsujitani S; Okuyama T; Watanabe A; Abe Y; Maehara Y; Sugimachi K
    Anticancer Res; 1993; 13(5C):1831-4. PubMed ID: 8267388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer.
    Samel S; Singal A; Becker H; Post S
    Eur J Surg Oncol; 2000 Apr; 26(3):222-6. PubMed ID: 10753533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
    Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
    Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer.
    Malmström H; Rasmussen S; Simonsen E
    Gynecol Oncol; 1993 May; 49(2):166-71. PubMed ID: 8504983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety and efficacy of hypotonic CDDP intraperitoneal administration for gastric cancer with peritoneal dissemination].
    Bamba T; Kanda T; Ohashi M; Hanyu T; Sakamoto K; Ishikawa T; Yajima K; Makino S; Tanabe T; Kosugi S; Hatakeyama K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1695-7. PubMed ID: 16315912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up.
    Schuhmacher CP; Fink U; Becker K; Busch R; Dittler HJ; Mueller J; Siewert JR
    Cancer; 2001 Mar; 91(5):918-27. PubMed ID: 11251943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the combination of chemotherapy with etoposide, adriamycin and cisplatin (EAP) in advanced or recurrent gastric cancer].
    Terata N; Sano H; Ishibashi H; Tani T; Hanasawa K; Endo Y; Kurumi Y; Shibata J; Kodama M; Tsuji K
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):611-6. PubMed ID: 8470918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide.
    Zimm S; Cleary SM; Lucas WE; Weiss RJ; Markman M; Andrews PA; Schiefer MA; Kim S; Horton C; Howell SB
    Cancer Res; 1987 Mar; 47(6):1712-6. PubMed ID: 3815369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
    Persiani R; Rausei S; Pozzo C; Biondi A; Barone C; Cananzi FC; Schinzari G; D'Ugo D
    Ann Surg Oncol; 2008 Aug; 15(8):2146-52. PubMed ID: 18543037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy comprising 5-fluorouracil, leucovorin, etoposide, and cis-diamminedichloroplatinum for the treatment of advanced gastric cancer.
    Mochizuki F; Fujii M; Kasakura Y; Yamagata M; Kochi M; Wakabayashi K; Kanamori N; Takayama T
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):493-6. PubMed ID: 12242513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy.
    Jeung HC; Rha SY; Jang WI; Noh SH; Chung HC
    Br J Surg; 2002 Apr; 89(4):460-6. PubMed ID: 11952588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advanced and recurrent gastric carcinoma: combination chemotherapy with etoposide (E), adriamycin (A), cisplatin (P) = EAP].
    Ohwada S; Miyamoto Y; Takeshita M; Fujii T; Uchida O; Tanahasi Y; Aoyagi H; Izuo M
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3487-9. PubMed ID: 2802641
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].
    Yabusaki H; Nashimoto A; Tanaka O
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1933-40. PubMed ID: 14650962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraperitoneal chemotherapy in gastric cancer patients with peritoneal dissemination].
    Hirono Y; Katayama K; Murakami M; Iida A; Yamaguchi A
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1404-9. PubMed ID: 16227738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics and toxicological study on the intraperitoneal administration of cisplatin and etoposide in gynecological malignancies].
    Fujimoto R; Yanagawa Y; Yamada T; Ueki K; Takahara T; Kumagai K; Okamura S; Ueki M; Sugimoto O
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1843-9. PubMed ID: 1519927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peritoneal dissemination of scirrhous type 4 gastric cancers].
    Koufuji K; Aoyagi K; Yano S; Murakami N; Miyagi M; Imaizumi T; Shirouzu K
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1384-8. PubMed ID: 16227734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of intraperitoneal chemotherapy using new-aged drugs for the peritoneal dissemination of gastric cancer].
    Fushida S; Fujita H; Kinami S; Ninomiya I; Fujimura T; Nishimura G; Ohta T
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1691-4. PubMed ID: 16315911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etoposide, doxorubicin, cisplatin and 5-FU (EAP-F) therapy of advanced gastric cancer--its antitumor effect and evaluation of quality of life].
    Suda K; Kano Y; Inada T; Ogata Y
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1791-5. PubMed ID: 8379671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.